GO
Loading...

Brainteaser: Can an iPad game detect Alzheimer’s?

Thursday, 9 Jan 2014 | 8:59 AM ET
Andrey Rudakov | Bloomberg | Getty Images

The pharmaceutical giant Pfizer has struck a deal with therapeutic game developer Akili Interactive Labs to test whether Project:EVO, which runs on iPhones and iPads, can discern cognitive differences in healthy older adults at risk of developing Alzheimer's disease. The agreement will be announced Thursday morning.

Read the entire story here.

By James Temple, recode.net.

CNBC's parent NBC Universal is an investor in re/code's parent Revere Digital, and the companies have a content-sharing arrangement.

  Price   Change %Change
PFE
---

Featured

Contact Technology

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More
  • Matt Hunter is the senior technology editor at CNBC.com.

  • Cadie Thompson is a tech reporter for the Enterprise Team for CNBC.com.

  • Working from Los Angeles, Boorstin is CNBC's media and entertainment reporter and editor of CNBC.com's Media Money section.

  • Jon Fortt is an on-air editor. He covers the companies, start-ups, and trends that are driving innovation in the industry.

  • Lipton is CNBC's technology correspondent, working from CNBC's Silicon Valley bureau.

  • Mark is CNBC's Silicon Valley/San Francisco Bureau Chief covering technology and digital media.